T-cell Surface Glycoprotein CD4 (CD4) Antibody
abx231475-100ug	Abbexa	100 ug	EUR 610.8

Human IgG antibody Laboratories manufactures the spike-specific cd4 t-cell sars test reagents distributed by Genprice. The Spike-Specific Cd4 T-Cell Sars Test reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Test. Other Spike-Specific products are available in stock. Specificity: Spike-Specific Category: Cd4 Group: T-Cell Sars

T-cell Surface Glycoprotein CD4 (CD4) Antibody
Abbexa	0.2 mg	EUR 886.8

T-cell Surface Glycoprotein CD4 (CD4) Antibody
Abbexa	EUR 493.20 EUR 710.40 EUR 218.40 EUR 376.80	100 ul 200 ul 20 ul 50 ul

T-cell Surface Glycoprotein CD4 (CD4) Antibody
Abbexa	0.25 mg	EUR 710.4

T-cell Surface Glycoprotein CD4 (CD4) Antibody
Abbexa	0.25 mg	EUR 678

T-cell Surface Glycoprotein CD4 (CD4) Antibody
Abbexa	0.25 mg	EUR 678

T-cell Surface Glycoprotein CD4 (CD4) Antibody
Abbexa	1 mg	EUR 994.8

T-cell Surface Glycoprotein CD4 (CD4) Antibody
Abbexa	0.25 mg	EUR 678

T-Cell Sars information

SARS-CoV Spike Antibody
3221-002mg	ProSci	0.02 mg	EUR 206.18
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3221-01mg	ProSci	0.1 mg	EUR 523.7
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3223-002mg	ProSci	0.02 mg	EUR 206.18
Description: SARS Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3223-01mg	ProSci	0.1 mg	EUR 523.7
Description: SARS Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

anti- Kv1.4-Specific antibody
FNab04664	FN Test	100µg	EUR 606.3
Description: Antibody raised against Kv1.4-Specific

anti- TUBB3 specific antibody
FNab09890	FN Test	100µg	EUR 658.5
Description: Antibody raised against TUBB3 specific

anti- REDD1 specific antibody
FNab07228	FN Test	100µg	EUR 658.5
Description: Antibody raised against REDD1 specific

anti- TDRKH specific antibody
FNab08580	FN Test	100µg	EUR 658.5
Description: Antibody raised against TDRKH specific

SARS-CoV-2 Spike Peptide
9083P	ProSci	0.05 mg	EUR 235.5
Description: (NT) SARS-CoV-2 Spike peptide

SARS-CoV-2 Spike Peptide
9087P	ProSci	0.05 mg	EUR 235.5
Description: (CT) SARS-CoV-2 Spike RBD peptide

SARS-CoV-2 Spike Peptide
9091P	ProSci	0.05 mg	EUR 235.5
Description: (IN) SARS-CoV-2 Spike peptide

SARS-CoV-2 Spike Peptide
9095P	ProSci	0.05 mg	EUR 235.5
Description: (IN) SARS-CoV-2 Spike peptide

anti- SCN9A/Nav1.7-Specific antibody
FNab07646	FN Test	100µg	EUR 702
Description: Antibody raised against SCN9A/Nav1.7-Specific

anti- Claudin 4-specific antibody
FNab01739	FN Test	100µg	EUR 606.3
Description: Antibody raised against Claudin 4-specific

anti- Claudin 9-specific antibody
FNab01741	FN Test	100µg	EUR 606.3
Description: Antibody raised against Claudin 9-specific

Human T- cell specific GTPase ELISA Kit
ELA-E1709h	Lifescience Market	96 Tests	EUR 988.8

Spike (SARS-CoV-2) Lentivirus
78010-1	BPS Bioscience	100 µl	EUR 835
Description: Cell entry of SARS-CoV-2 depends on the binding of viral spike protein to cellular receptor ACE2. The SARS-CoV-2 Spike Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types mammalian cells, including primary and non-dividing cells. The particles contain the full length SARS-CoV-2 spike gene (QHD43416.1) driven by an EF1a promoter._x000D_